Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

Thomas J. Guzzo(Hospital of the University of Pennsylvania), S. Bruce Malkowicz(Hospital of the University of Pennsylvania), Meredith Bergey(Brandeis University), Alan J. Wein(University of Miami), Trinity J. Bivalacqua(University of Pennsylvania), John E. Tomazewski(Hospital of the University of Pennsylvania), Laurie Magerfleisch(Hospital of the University of Pennsylvania), Mark Rosen(California University of Pennsylvania), Matthew J. Resnick(Vanderbilt University Medical Center), Daniel Canter(Ochsner Medical Center)
Urologic Oncology Seminars and Original Investigations
August 18, 2011
Cited by 38


Related Papers